Microbiology & Infectious Diseases

Gut bacteria influence HIV reservoir size and activity differently across GI segments, offering insights for targeted cure strategies.

HCV incidence among people who inject drugs in Scotland has halved since 2015, bringing WHO elimination targets within reach.

A new two-dose Salmonella Paratyphi A vaccine offers 73% protection in adults and shows strong safety and immune responses, addressing a major public health need.

Study of 2,061 infants reveals RSV, HMPV, influenza, and viral co-infections significantly increase severe lower respiratory illness risk.

Children face over twice the risk of paediatric long COVID after SARS-CoV-2 reinfection, highlighting urgent needs for prevention.

A USA cohort study finds persistent olfactory dysfunction up to 2 years after COVID-19, even in people unaware of smell loss.

New study shows oral microbiome imbalance and reduced salivary hypotaurine may contribute to neuroinflammation in relapsing-remitting MS.

EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.